Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance

American Journal of Physiology - Endocrinology and Metabolism

Volumn 306, Issue 6, 2014, Pages

  Huong Do, Thi Thu ^a,b,c   Hindlet, Patrick ^d,e   Dupriet Waligora, Anne Judith ^f   Kapel, Nathalie ^f,g   Neveux, Nathalie ^f,h   Mignon, Virginie ^f   Deloménie, Claudine ^d   Farinotti, Robert ^d   Fève, Bruno ^a,b,c,e   Buyse, Marion ^b,c,d,e  

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c Institute of Cardiometabolism and Nutrition   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h HÔTEL DIEU   (France)

Author keywords

Gut microbiota; Peptide cotransporter 1 Slc15a1; Type 2 diabetes

Indexed keywords

DNA; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUCOSE; INSULIN; NITROGEN; PEPTIDE TRANSPORTER 1;

ABSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DIGESTION; DNA CONTENT; DOWN REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HOMEOSTASIS; INSULIN RESISTANCE; INTESTINE; INTESTINE BRUSH BORDER; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPID DIET; MALE; MOUSE; NITROGEN HOMEOSTASIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

GUT MICROBIOTA; PEPTIDE COTRANSPORTER-1 SLC15A1; TYPE 2 DIABETES;

ALLOSTASIS; AMINO ACID TRANSPORT SYSTEMS; AMINO ACIDS; ANIMALS; DIET, HIGH-FAT; DIPEPTIDYL PEPTIDASE 4; DISEASE MODELS, ANIMAL; DNA; FECES; GENE EXPRESSION REGULATION; GLUCOSE INTOLERANCE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; INTESTINES; MALE; MICE; MICE, INBRED C57BL; NITROGEN; OBESITY; SYMPORTERS;

EID: 84900543465     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00437.2013     Document Type: Article

References (62)

1. Adibi SA. The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology 113: 332-340, 1997.
2. Akpinar O, Penner MH. Peptidase Activity Assays Using Protein Substrates. In: Current Protocols in Food Analytical Chemistry. Baltimore, MD: Wiley, 2002, p. 1-10.
3. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101: 15718-15723, 2004.
4. Baldassano S, Amato A, Cappello F, Rappa F, Mule F. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. J Endocrinol 217: 11-20, 2013.
5. Basilisco G, Camboni G, Bozzani A, Vita P, Doldi S, Bianchi PA. Orocecal transit delay in obese patients. Dig Dis Sci 34: 509-512, 1989.
6. Batch BC, Shah SH, Newgard CB, Turer CB, Haynes C, Bain JR, Muehlbauer M, Patel MJ, Stevens RD, Appel LJ, Newby LK, Svetkey LP. Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness. Metab Clin Exp 62: 961-969, 2013.
7. Bernard JR, Liao YH, Ding Z, Hara D, Kleinert M, Nelson JL, Ivy JL. An amino acid mixture improves glucose tolerance and lowers insulin resistance in the obese Zucker rat. Amino Acids 45: 191-203, 2013.
8. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palu G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292: G518-G525, 2007.
9. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemiainduced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481, 2008.
10. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103, 2009.
11. Casirola DM, Vinnakota RR, Ferraris RP. Intestinal amino acid transport in mice is modulated by diabetes and diet. J Nutr 124: 842-852, 1994.
12. Davidenko O, Darcel N, Fromentin G, Tome D. Control of protein and energy intake: brain mechanisms. Eur J Clin Nutr 67: 455-461, 2013.
13. Davila AM, Blachier F, Gotteland M, Andriamihaja M, Benetti PH, Sanz Y, Tome D. Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. Pharmacol Res 68: 95-107, 2013.
14. De Bandt JP, Waligora-Dupriet AJ, Butel MJ. Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care 14: 334-340, 2011.
15. Dyer J, Wood IS, Palejwala A, Ellis A, Shirazi-Beechey SP. Expression of monosaccharide transporters in intestine of diabetic humans. Am J Physiol Gastrointest Liver Physiol 282: G241-G248, 2002.
16. Erickson RH, Gum JR Jr, Lindstrom MM, McKean D, Kim YS. Regional expression and dietary regulation of rat small intestinal peptide and amino acid transporter mRNAs. Biochem Biophys Res Commun 216: 249-257, 1995.
17. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH. Plasma metabolomic profiles reflective of glucose homeostasis in nondiabetic and type 2 diabetic obese African-American women. PloS one 5: e15234, 2010.
18. Fishman L, Lenders C, Fortunato C, Noonan C, Nurko S. Increased prevalence of constipation and fecal soiling in a population of obese children. J Pediatr 145: 253-254, 2004.
19. Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J Parenter Enteral Nutr 35: 14S-20S, 2011.
20. Freeman HJ, Kim YS. Digestion and absorption of protein. Ann Rev Med 29: 99-116, 1978.
21. Furet JP, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S, Dore J, Corthier G. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiol Ecol 68: 351-362, 2009.
22. Hidalgo IJ, Borchardt RT. Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim Biophys Acta 1028: 25-30, 1990.
23. Hindlet P, Bado A, Kamenicky P, Delomenie C, Bourasset F, Nazaret C, Farinotti R, Buyse M. Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation. J Biol Chem 284: 6801-6808, 2009.
24. Hino M, Fuyamada H, Hayakawa T, Nagatsu T, Oya H. X-Prolyl dipeptidyl-aminopeptidase activity, with X-proline p-nitroanilides as substrates, in normal and pathological human sera. Clin Chem 22: 1256-1261, 1976.
25. Huijsdens XW, Linskens RK, Mak M, Meuwissen SG, Vandenbroucke-Grauls CM, Savelkoul PH. Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR. J Clin Microbiol 40: 4423-4427, 2002.
26. Kalach N, Kapel N, Waligora-Dupriet AJ, Castelain MC, Cousin MO, Sauvage C, Ba F, Nicolis I, Campeotto F, Butel MJ, Dupont C. Intestinal permeability and fecal eosinophil-derived neurotoxin are the best diagnosis tools for digestive non-IgE-mediated cow's milk allergy in toddlers. Clin Chem Lab Med 51: 351-361, 2013.
27. Kashyap PC, Marcobal A, Ursell LK, Larauche M, Duboc H, Earle KA, Sonnenburg ED, Ferreyra JA, Higginbottom SK, Million M, Tache Y, Pasricha PJ, Knight R, Farrugia G, Sonnenburg JL. Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice. Gastroenterology 144: 967-977, 2013.
28. Kiely JM, Noh JH, Svatek CL, Pitt HA, Swartz-Basile DA. Altered small intestinal absorptive enzyme activities in leptin-deficient obese mice: influence of bowel resection. J Pediatr Surg 41: 1243-1249, 2006.
29. Kolodziejczak D, Spanier B, Pais R, Kraiczy J, Stelzl T, Gedrich K, Scherling C, Zietek T, Daniel H. Mice lacking the intestinal peptide transporter display reduced energy intake and a subtle maldigestion/ malabsorption that protects them from diet-induced obesity. Am J Physiol Gastrointest Liver Physiol 304: G897-G907, 2013.
30. Kostic AD, Howitt MR, Garrett WS. Exploring host-microbiota interactions in animal models and humans. Genes Dev 27: 701-718, 2013.
31. Leenders M, van Loon LJ. Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes. Nutr Rev 69: 675-689, 2011.
32. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 70: 7220-7228, 2004.
33. Misra S, Lee A, Gensel K. Chronic constipation in overweight children. J Parenter Enteral Nutr 30: 81-84, 2006.
34. Mithieux G. A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition 25: 881-884, 2009.
35. Moe AJ, Pocius PA, Polan CE. Isolation and characterization of brush border membrane vesicles from bovine small intestine. J Nutr 115: 1173-1179, 1985.
36. Morita A, Chung YC, Freeman HJ, Erickson RH, Sleisenger MH, Kim YS. Intestinal assimilation of a proline-containing tetrapeptide. Role of a brush border membrane postproline dipeptidyl aminopeptidase IV. J Clin Invest 72: 610-616, 1983.
37. Nakabou Y, Ishikawa Y, Misake A, Hagihira H. Effect of food intake on intestinal absorption and mucosal hydrolases in alloxan diabetic rats. Metab Clin Exp 29: 181-185, 1980.
38. Nässl AM, Rubio-Aliaga I, Fenselau H, Marth MK, Kottra G, Daniel H. Amino acid absorption and homeostasis in mice lacking the intestinal peptide transporter PEPT1. Am J Physiol Gastrointest Liver Physiol 301: G128-G137, 2011.
39. Neveux N, David P, Cynober L. Measurement of amino acid concentration in biological fluids and tissues using ion-exchange chromatography. In: Metabolic and Therapeutic Aspects of Amino Acids in Clinical Nutrition, edited by Cynober. LCRC Press, 2004, p. 17-28.
40. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS Jr, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326, 2009.
41. Newsholme P, Bender K, Kiely A, Brennan L. Amino acid metabolism, insulin secretion and diabetes. Biochem Soc Trans 35: 1180-1186, 2007.
42. Penhoat A, Mutel E, Amigo-Correig M, Pillot B, Stefanutti A, Rajas F, Mithieux G. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol Behav 105: 89-93, 2011.
43. Previs SF, Brunengraber DZ, Brunengraber H. Is there glucose production outside of the liver and kidney? Ann Rev Nutr 29: 43-57, 2009.
44. Promintzer M, Krebs M. Effects of dietary protein on glucose homeostasis. Curr Opin Clin Nutr Metab Care 9: 463-468, 2006.
45. Puiman P, Stoll B, Molbak L, de Bruijn A, Schierbeek H, Boye M, Boehm G, Renes I, van Goudoever J, Burrin D. Modulation of the gut microbiota with antibiotic treatment suppresses whole body urea production in neonatal pigs. Am J Physiol Gastrointest Liver Physiol 304: G300-G310, 2013.
46. Rana S, Bhansali A, Bhadada S, Sharma S, Kaur J, Singh K. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India. Diabetes Technol Ther 13: 1115-1120, 2011.
47. Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97: 1166-1177, 2004.
48. Rubio-Aliaga I, Daniel H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 38: 1022-1042, 2008.
49. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 124: 293-302, 2003.
50. Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70: 6459-6465, 2004.
51. Stevens BR, Wright EM. Substrate specificity of the intestinal brushborder proline/sodium (IMINO) transporter. J Membr Biol 87: 27-34, 1985.
52. Tai ES, Tan ML, Stevens RD, Low YL, Muehlbauer MJ, Goh DL, Ilkayeva OR, Wenner BR, Bain JR, Lee JJ, Lim SC, Khoo CM, Shah SH, Newgard CB. Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53: 757-767, 2010.
53. Te Morenga L, Mann J. The role of high-protein diets in body weight management and health. Br J Nutr 108, Suppl 2: S130-S138, 2012.
54. Terada T, Inui K. Gene expression and regulation of drug transporters in the intestine and kidney. Biochem Pharmacol 73: 440-449, 2007.
55. Thwaites DT, Anderson CM. Deciphering the mechanisms of intestinal imino (and amino) acid transport: the redemption of SLC36A1. Biochim Biophys Acta 1768: 179-197, 2007.
56. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031, 2006.
57. van Loon LJ, Kruijshoop M, Menheere PP, Wagenmakers AJ, Saris WH, Keizer HA. Amino acid ingestion strongly enhances insulin secretion in patients with long-term type 2 diabetes. Diabetes Care 26: 625-630, 2003.
58. van Loon LJ, Kruijshoop M, Verhagen H, Saris WH, Wagenmakers AJ. Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr 130: 2508-2513, 2000.
59. van Loon LJ, Saris WH, Verhagen H, Wagenmakers AJ. Plasma insulin responses after ingestion of different amino acid or protein mixtures with carbohydrate. A J Clin Nutr 72: 96-105, 2000.
60. Veldhorst MA, Westerterp-Plantenga MS, Westerterp KR. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. A J Clin Nutr 90: 519-526, 2009.
61. Wuensch T, Schulz S, Ullrich S, Lill N, Stelzl T, Rubio-Aliaga I, Loh G, Chamaillard M, Haller D, Daniel H. The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am J Physiol Gastrointest Liver Physiol 305: G66-G73, 2013.
62. Yang J, Campitelli J, Hu G, Lin Y, Luo J, Xue C. Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin. Life Sci 81: 272-279, 2007.